NASDAQ:CFMSConforMIS Stock Price, Forecast & News

ConforMIS's stock was trading at $0.66 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, CFMS shares have increased by 24.3% and is now trading at $0.8207. View which stocks have been most impacted by Coronavirus.

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for ConforMIS in the last year. There are currently 1 hold rating and 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for ConforMIS.

ConforMIS is scheduled to release its next quarterly earnings announcement on Wednesday, July 29th 2020. View our earnings forecast for ConforMIS.

ConforMIS Inc (NASDAQ:CFMS) issued its quarterly earnings data on Monday, May, 11th. The medical instruments supplier reported ($0.14) earnings per share for the quarter, missing the Zacks' consensus estimate of ($0.10) by $0.04. The medical instruments supplier had revenue of $16.48 million for the quarter, compared to analyst estimates of $18.95 million. ConforMIS had a negative net margin of 41.29% and a negative return on equity of 165.61%. View ConforMIS's earnings history.

ConforMIS issued an update on its second quarter 2020 Pre-Market earnings guidance on Monday, July, 6th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $19.5-19.5 million, compared to the consensus revenue estimate of $4.84 million.

4 brokers have issued 1 year price objectives for ConforMIS's shares. Their forecasts range from $2.00 to $3.00. On average, they anticipate ConforMIS's stock price to reach $2.33 in the next twelve months. This suggests a possible upside of 184.3% from the stock's current price. View analysts' price targets for ConforMIS.

Media stories about CFMS stock have been trending very negative recently, InfoTrie Sentiment reports. The research firm identifies negative and positive press coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. ConforMIS earned a daily sentiment score of -3.2 on InfoTrie's scale. They also assigned press coverage about the medical instruments supplier a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the stock's share price in the near term. View the latest news about ConforMIS.

ConforMIS saw a increase in short interest in June. As of June 30th, there was short interest totaling 2,560,000 shares, an increase of 8.9% from the June 15th total of 2,350,000 shares. Based on an average daily trading volume, of 590,800 shares, the short-interest ratio is currently 4.3 days. Approximately 4.1% of the shares of the company are sold short. View ConforMIS's Current Options Chain.

Some companies that are related to ConforMIS include Invacare (IVC), RTI Surgical (RTIX), Sientra (SIEN), Lakeland Industries (LAKE), COLLPLANT HOLDI/S (CLGN), Allied Healthcare Products (AHPI), Histogenics (HSGX), Precision Therapeutics (POAI), Rewalk Robotics (RWLK), Ocugen (OCGN), NanoVibronix (NAOV), Bionik Laboratories (BNKL) and Avitar (AVTI). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other ConforMIS investors own include Martin Midstream Partners (MMLP), Micron Technology (MU), NVIDIA (NVDA), Cisco Systems (CSCO), AT&T (T), Advanced Micro Devices (AMD), Alibaba Group (BABA), AbbVie (ABBV), Pfizer (PFE) and Starbucks (SBUX).

(CFMS) raised $135 million in an IPO on Wednesday, July 1st 2015. The company issued 9,000,000 shares at a price of $14.00-$16.00 per share. J.P. Morgan and Deutsche Bank Securities acted as the underwriters for the IPO and Wells Fargo Securities and Canaccord Genuity were co-managers.

ConforMIS trades on the NASDAQ under the ticker symbol "CFMS."

Shares of CFMS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of CFMS stock can currently be purchased for approximately $0.82.

ConforMIS has a market capitalization of $58.66 million and generates $77.43 million in revenue each year. The medical instruments supplier earns $-28,480,000.00 in net income (profit) each year or ($0.44) on an earnings per share basis. ConforMIS employs 262 workers across the globe.

The official website for ConforMIS is www.conformis.com.

ConforMIS's mailing address is 600 TECHNOLOGY PARK DRIVE, BILLERICA MA, 01821. The medical instruments supplier can be reached via phone at 781-345-9001 or via email at [email protected]